348 related articles for article (PubMed ID: 18704420)
21. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
[TBL] [Abstract][Full Text] [Related]
23. B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
Zaja F; Vianelli N; Sperotto A; De Vita S; Iacona I; Zaccaria A; Masolini P; Tomadini V; Tani M; Molinari AL; Baccarani M; Fanin R
Haematologica; 2003 May; 88(5):538-46. PubMed ID: 12745273
[TBL] [Abstract][Full Text] [Related]
24. Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
Srinivasan S; Sabapathy K; Bharadwaj TP; Sethuraman S
J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258
[TBL] [Abstract][Full Text] [Related]
25. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
Cooper N; Evangelista ML; Amadori S; Stasi R
Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
[TBL] [Abstract][Full Text] [Related]
26. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses.
Kumar S; Diehn FE; Gertz MA; Tefferi A
Ann Hematol; 2002 Jun; 81(6):312-9. PubMed ID: 12107560
[TBL] [Abstract][Full Text] [Related]
27. Chronic idiopathic thrombocytopenic purpura (ITP) is a surgical disease.
Szold A; Kais H; Keidar A; Nadav L; Eldor A; Klausner JM
Surg Endosc; 2002 Jan; 16(1):155-8. PubMed ID: 11961628
[TBL] [Abstract][Full Text] [Related]
28. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
Zhou Z; Yang R
Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
Delgado J; Bustos JG; Jimenez-Yuste V; Hernandez-Navarro F
Haematologica; 2002 Feb; 87(2):215-6. PubMed ID: 11836172
[TBL] [Abstract][Full Text] [Related]
30. Rituximab use in pediatric autoimmune diseases: four case reports.
Polido-Pereira J; Ferreira D; Rodrigues AM; Nascimento C; Costa P; Almeida M; da Silva JE; Simão C; Stone R; Ramos F; Neto A; da Costa JC; Melo-Gomes J; Gomes-Pedro J; Viana-Queiroz M; Canhão H; Fonseca JE
Ann N Y Acad Sci; 2009 Sep; 1173():712-20. PubMed ID: 19758220
[TBL] [Abstract][Full Text] [Related]
31. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center.
Ismet A; Irfan K; Emin K; AlI EM; Ramazan U; Mustafa B; Onur O
Clin Lab Haematol; 2004 Jun; 26(3):211-4. PubMed ID: 15163320
[TBL] [Abstract][Full Text] [Related]
32. Rituximab treatment for symptomatic chronic ITP.
Tamminga RY; Bruin MC
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):714-6. PubMed ID: 16933264
[TBL] [Abstract][Full Text] [Related]
33. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
Kuwana M; Iki S; Urabe A
Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
[TBL] [Abstract][Full Text] [Related]
34. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
[TBL] [Abstract][Full Text] [Related]
35. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
Aggarwal A; Catlett JP
South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia].
Zhu YC; Wang W; Zhou YH; Wang XM; Wang X; Wang YL; Sun GZ; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953
[TBL] [Abstract][Full Text] [Related]
37. Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group.
Kühne T; Blanchette V; Buchanan GR; Ramenghi U; Donato H; Tamminga RY; Rischewski J; Berchtold W; Imbach P;
Pediatr Blood Cancer; 2007 Nov; 49(6):829-34. PubMed ID: 17171689
[TBL] [Abstract][Full Text] [Related]
38. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of idiopathic thrombocytopenic purpura with danazol].
Ruberto E; Espinola R
Sangre (Barc); 1995 Aug; 40(4):307-10. PubMed ID: 7482120
[TBL] [Abstract][Full Text] [Related]
40. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
Zaja F; Marin L; Chiozzotto M; Puglisi S; Volpetti S; Fanin R
Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
